Skip to Main Content
Diseases of the Cardiovascular System

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after Coronary Artery Bypass Surgery

What is the purpose of this trial?

PACeS is a trial to study most effective treatment for patients who may experience atrial fibrillation after cardiac surgery, particularly coronary artery bypass grafting (CABG). Atrial fibrillation, or Afib (AF), is an irregular heart rhythm. In some cases, AF can cause blood clots. There are currently 2 classes of drugs for preventing blood clots in patients with AF. Antiplatelets, like aspirin, and anticoagulants, or blood thinners. This study aims to determine whether the addition of blood thinners to antiplatelets will improve treatment outcomes in patients who develop AF after CABG.

  • Trial with
    Icahn School of Medicine at Mount Sinai (ISMMS)
  • Ages
    18 years and older
  • Gender
    Both

Contact Information

For more information about this study, including how to volunteer, contact Matthew Williams

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

  • Last Updated
    10/04/2024
  • Study HIC
    #2000027269